Home Page

Welcome to the McGill International Tuberculosis Centre - A PAHO/WHO Collaborating Centre for Tuberculosis Research      


It's time to End Drug-Resistant TB : The case for Action

 

        

 

 

 

 

Read the full report from The Economist Intelligence Unit here


Joint seminar IDIGH-TB Centre

Dr. Madhukar Pai will be giving a talk on May 22nd: The dark side of medical publishing: predators, pirates and profiteers.

Location: 1001, Boulevard Décarie, Bloc E, EM1.3509


Postdoctoral Fellowship in Tuberculosis & Private Provider Engagement - 2019-2020

The postdoctoral fellow will function as a junior investigator, participating fully in teaching, research and related scholarly activities and would be encouraged to apply for independent salary and research funding. Specifically, the fellow would contribute to research on Public-Private Mix and TB, private provider engagement, quality of TB care in the private health sector, and contribute to a learning network (i.e. community of practice) around private provider engagement and TB. Travel abroad will be required.
Important note: This is NOT a laboratory-based (bench science) fellowship.
 

Click here for more information


Dick Menzies receives Distinguished Lecturer Award

Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at McGill and McGill’s World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award in Respiratory Sciences.

Each year, the Distinguished Lecturer Award (DLA) Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) scientific research community who have contributed significantly to the advancement of science in their field of research both in Canada and internationally.

Read more


Dr. Marcel Behr received Tier 1 Canada Research Chair

Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once. 

Chairholder title: Mycobacterial Genomics


Recent media appearances

Four Burning Questions for Madhukar Pai and Dick Menzies on World TB Day in MedE-News

Des chercheurs montréalais s'affairent à éradiquer la tuberculose in La Presse

 

For a world without tuberculosis

Building a tuberculosis-free world in The Lancet Commission on tuberculosis

We Have A New Roadmap To A World Without Tuberculosis in The Huffington Post

A human-rights approach is essential to end the global TB epidemic in The Conversation

Inuit research raises concerns about tuberculosis eradication in The Lancet


Research Day 2019

Read the full program


Dr. Marcel Behr elected to Fellowship in the AAM

Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, and leadership in the microbiological sciences, and his election to this group is a mark of distinction. Congratulations Dr. Behr!


Message from the Director:

With over 10 million new TB cases, and 1.6 million deaths, TB is the leading infectious killer of humanity. In Canada, the TB rate among the Inuit is about 283 times higher than that of the Canadian-born non-Indigenous. Thankfully, the world has committed to end the TB epidemic by 2030, and the Canadian government has pledged to end the TB epidemic in the Inuit Nunangat by 2030. The McGill International TB Centre is a world leader in the interdisciplinary study of TB. This Centre brings together more than 20 investigators with expertise in biomedical, clinical, epidemiologic and social aspects of TB. We work to better understand TB pathogenesis and host resistance, and also develop and evaluate new diagnostics, vaccines and treatment regimens for the control of TB. By means of quality training, technical assistance, capacity building, and policy-relevant research, our Centre aims to make a positive contribution to ending the TB epidemic nationally as well as globally.

Madhukar Pai,

December 3rd, 2018


Recent Media Appearances


 


 


Confronting a killer : New article about the McGill TB Centre written by Patrick McDonagh in McGill News

THE INTERNATIONAL COMMUNITY IS TURNING ITS ATTENTION TO THE MENACE OF TB AND A RESEARCH CENTRE AT MCGILL IS ALREADY PLAYING A MAJOR ROLE.

Read more


McGill International TB Centre designated as a PAHO/WHO Collaborating Center for Tuberculosis Research

more about Paho/WHO CC


Great job at knowledge synthesis by TB Centre researchers
Nature Review Primer on TB.

Just got designated as a ‘Highly cited paper’ by the Web of Science, meaning it is among the top 1% of papers of similar age in the field of clinical medicine! Read it here: http://go.nature.com/2Da2w2q 


The top-cited systematic reviews/meta-analyses in tuberculosis research

McGill authors topped the rankings as first and corresponding authors in systematic reviews and meta-analyses in TB research.


The 100 top-cited tuberculosis research studies

According to a study, McGill researchers account for 6% of the world's best cited TB papers which is very high ranking! The 100 top-cited tuberculosis research https://www.atsjournals.org/doi/10.1164/rccm.201707-1489PPstudies (International Union Against Tuberculosis and Lung Disease) Download


Positions in Tuberculosis Research Available:

 

Our centre brings together over 20 investigators with expertise spanning epidemiology, policy setting, economic analyses, implementation research, meta-analyses,  qualitative research to basic science in microbiology, host genetics and immune response. 

The work is done both at an academic centre and with a number of collaborating groups around the world. On these pages, we introduce the faculty members who are members of our centre and describe our training programs for students.  Find out why our Centre is a world leader in the interdisciplinary study of TB and how we work together to unravel the many mysteries of this recalcitrant disease.